Viewing Study NCT01585558

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2026-02-23 @ 8:08 PM
Study NCT ID: NCT01585558
Status: COMPLETED
Last Update Posted: 2018-05-21
First Post: 2012-04-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus
Sponsor: Shionogi
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atrophy View
None Vaginal Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Menopausal symptoms View
None Urogenital atrophy View
None Vulvar and vaginal atrophy in menopausal women View
None Vaginal atrophy View